KPV: Benefits, Dosage, Side Effects, and How to Get It in 2026
Medically reviewed by the Rite Aid Health Team · Last updated
Evidence and status
- Approval status
- Not FDA approved
- Strongest support
- Animal and laboratory research
- Route context
- Reported oral, topical, and injectable use; no approved route
- Competitive sport
- Check current sport rules
KPV is a three-amino-acid peptide studied for inflammation, gut health, immune response, and skin conditions. It forms part of alpha-MSH, a hormone involved in inflammatory signaling.
Get the Free Peptide Tracking Toolkit
KPV + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
What is KPV?
KPV is a tripeptide made of three amino acids: lysine (K), proline (P), and valine (V). It is the C-terminal fragment of alpha-MSH (alpha-melanocyte-stimulating hormone), a naturally occurring hormone with anti-inflammatory activity.
KPV keeps the short amino-acid sequence associated with alpha-MSH's anti-inflammatory activity without its pigment-producing action. Oral, topical, injectable, and nasal products use that small size in different ways.
Benefits and uses
KPV research and reported use center on inflammation in three areas:
- Gut healing and inflammatory bowel conditions. In a cell and mouse colitis study, KPV entered intestinal cells through the PepT1 transporter and reduced inflammatory signaling. Oral KPV also reduced inflammation in two mouse models.
- Immune modulation. It downregulates inflammatory signaling broadly, which is why it is studied as a general anti-inflammatory rather than for one tissue alone.
- Skin inflammation. Laboratory work includes human keratinocytes and three-dimensional skin models. A 2025 study examined oxidative stress, inflammatory signaling, and cell survival after particulate exposure.
People using KPV report changes in digestive comfort, skin redness, irritation, and recovery-related inflammation. Those experiences explain why different oral and topical products exist. Human treatment trials have not yet defined how reliably those outcomes occur.
How it works
In intestinal cell experiments, KPV entered through PepT1 and reduced NF-kB activity. NF-kB is a signaling system that switches on many inflammatory genes.
The experiments also measured lower production of inflammatory cytokines. Researchers are studying whether that same intracellular mechanism can support useful outcomes in the gut and skin.
Dosage and administration
KPV appears in oral, topical, subcutaneous, and nasal products. People generally match oral products with gut goals, topical products with skin goals, and injections with systemic use.
There is no standardized dose or schedule across those routes. Published oral and topical experiments also use different formulations from the products marketed by clinics.
Injectable vials may require reconstitution. The peptide dosage calculator converts a supplied dose and concentration into syringe units.
| Route | Why people choose it | Research context |
|---|---|---|
| Oral | Gut-focused use | The best-known study used oral KPV in mice, not people |
| Topical | Local skin application | Evidence includes cells, skin models, and delivery research |
| Injection or nasal | Systemic or alternative delivery | FDA found no human exposure data by any route |
Side effects and safety
KPV is often described as well tolerated because it is a small fragment of a natural hormone. Users generally report mild effects, although no human exposure study has measured their frequency.
FDA's 2026 assessment highlighted unanswered questions about immune reactions, aggregation, peptide impurities, identity, and microbiological quality. Route and product quality can change those risks.
Legal status and how to get it in 2026
The FDA removed KPV from its Section 503A Category 2 list in April 2026.
On , an FDA advisory committee recommended adding it to the Section 503A Bulks List. The committee considered wound healing and inflammatory conditions.
The vote was advisory. It was not drug approval, and the FDA has not made a final decision. Current access rules remain unchanged.
Products sold online for research use are not approved for human use. Their identity, strength, and quality may be uncertain.
Get the Free Peptide Tracking Toolkit
KPV + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
KPV in the healing stack
KPV is commonly assigned the inflammation-focused role in recovery stacks built around BPC-157 and TB-500.
Users describe BPC-157 as the local-repair component, TB-500 as the broader cell-migration component, and KPV as the inflammation component. The healing and recovery guide compares the evidence behind those roles.
Blood work to track KPV
KPV has no single direct blood marker. People commonly follow inflammation and general safety markers alongside the symptom or condition that led them to use it.
- hs-CRP — a broad measure of systemic inflammation that can be compared over time.
- Comprehensive metabolic profile — liver, kidney, glucose, and electrolyte measurements for broader context.
Test at baseline and again at 4–6 weeks.
Peptide Baseline Measurement Panel
Get your baseline- No doctor visit required
- 2,200+ Quest locations
- Results in 1–2 business days
References
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.
FAQ
Most commonly as an anti-inflammatory — for inflammatory bowel conditions, gut healing, immune modulation, and skin inflammation. The evidence is largely from cell and animal research; human clinical data is limited.
An FDA advisory committee recommended KPV for the Section 503A Bulks List in July 2026. The vote was not drug approval, and the FDA has not made a final decision. Research-only products are not approved for human use.
KPV is used orally, topically, or by subcutaneous injection depending on the target. There is no FDA-approved product or official dosing; dosing and route should be set by a prescribing provider.
Reported effects are generally mild. Long-term human safety data does not exist, which is the main caution.
It acts inside the cell to downregulate the NF-kB pathway, the signaling system that switches on inflammatory genes, reducing inflammatory signals at the source.
It varies by use and route. Inflammatory markers like hs-CRP may shift within the first few weeks of a cycle.